Skip to main content
Dabur India Ltd. logo

Dabur India Ltd. — Investor Relations & Filings

Ticker · DABUR ISIN · INE016A01026 LEI · 335800MJPUA2E1FSFL38 BSE.NS Manufacturing
Open in API
Filings indexed 2,054 across all filing types
Latest filing 2023-02-15 Regulatory Filings
Country IN India
Listing BSE.NS DABUR

About Dabur India Ltd.

https://www.dabur.com

Dabur India Ltd. specializes in Ayurvedic and natural healthcare solutions, managing a diverse portfolio across health supplements, oral care, hair care, skin care, home care, and food and beverages. Established in 1884, the organization integrates traditional Ayurvedic wisdom with modern scientific research to develop standardized herbal products. Key brands include Dabur Chyawanprash, Dabur Honey, Real fruit juices, Vatika, and Dabur Red Paste. The company maintains a robust research and development framework to support its focus on natural ingredients and holistic health. Its operations serve a wide demographic across international markets, emphasizing the synergy between nature and science through an extensive distribution network and a commitment to quality-driven consumer products.

Recent filings

Filing Released Lang Actions
Clarification /Confirmation on news item appearing in Media/Publication
Regulatory Filings
2023-02-15 English
News Verification
Regulatory Filings
2023-02-15 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2023-02-10 English
Schedule of Analyst/Institutional Investor Meet pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015
Regulatory Filings
2023-02-10 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a transcript of an investor conference call discussing Dabur India Limited's financial results for the quarter and nine months ended December 31, 2022. It includes detailed commentary from management on business performance, market share, product categories, and outlook, followed by a Q&A session with analysts. The presence of management speaking, detailed financial and operational discussion, and Q&A format are characteristic of an earnings call transcript. There is no indication that this is a formal report like an Annual Report or Interim Report, nor is it a brief earnings release. The document length (15,000 characters) and content confirm it is a full call transcript rather than a short announcement or presentation. Therefore, the appropriate classification is Call Transcript (CT).
2023-02-07 English
Transcript of Investors' Conference Call for Q3 FY 2022-23 Financial Results pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015
Call Transcript Classification · 100% confidence The document is a transcript of an investor conference call discussing Dabur India Limited's financial results for the quarter and nine months ended December 31, 2022. It includes detailed commentary from management on business performance, market share, product categories, and outlook, followed by a Q&A session with analysts. The presence of management speaking, detailed financial and operational discussion, and Q&A format clearly identify this as a Call Transcript (CT). The document length (15,000 characters) and content confirm it is not a brief announcement or summary but a full transcript of the earnings call.
2023-02-07 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.